What is the optimal fit-for-purpose design in an oncology first-in-human trial?: 3+3 vs. Bayesian Logistic Regression Model
- Author:
Sun Young YUM
1
Author Information
- Publication Type:Commentary
- From:Translational and Clinical Pharmacology 2020;28(1):1-6
- CountryRepublic of Korea
